Viewing Study NCT00620594

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:34 AM
Ignite Modification Date: 2026-03-06 @ 1:21 AM
Study NCT ID: NCT00620594
Status: COMPLETED
Last Update Posted: 2020-12-09
First Post: 2008-02-08
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase I/II Study of BEZ235 in Patients With Advanced Solid Malignancies Enriched by Patients With Advanced Breast Cancer
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
None Advanced Solid Tumors View
None Cowden Syndrome View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Neoplasms View
None breast neoplasms View
None breast diseases View
None solid tumors View
None BEZ235 View
None breast cancer View
None PI3K Inhibitor View
None Phosphatidylinositol 3 View
None kinase View
None advanced View